Hollow Mesoporous Silica@Zeolitic Imidazolate Framework Capsules and Their Applications for Gentamicin Delivery

Neural Plasticity
Xiaoxiang XuWeijia Kong

Abstract

We have synthesized hollow mesoporous silica (HMS) at a zeolitic imidazolate framework (ZIF) capsule that can be used as a drug delivery system for gentamicin (GM). The GM is first loaded into HMS. Then, the outer surface of the GM/HMS is coated with uniformed ZIF nanoparticles (denoted as GM/HMS@ZIF). The GM/HMS@ZIF has been successfully prepared and acts as a capsule for GM. The GM/HMS@ZIF shows a good biocompatibility and a good cellular uptake in House Ear Institute-Organ of Corti 1 (HEI-OC1) cells. The GM is released slowly within 10 h under acidic conditions, which is used to simulate the pH of the endosome and lysosome compartments. The in vivo assay shows that the signal from fluorescein isothiocyanate (FITC) can be observed after 15 days, when the mice were injected with FITC/HMS@ZIF. This opens new opportunities to construct a delivery system for GM via one controlled low dose and sustained release for the therapy of Ménière's disease.

References

Dec 19, 2002·Otolaryngologic Clinics of North America·Sady Selaimen da CostaMarcelo Ribeiro de Toledo Piza
May 17, 2003·Science·Nathaniel L RosiOmar M Yaghi
Jul 1, 1956·The Laryngoscope·H F SCHUKNECHT
Jun 27, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kyo Sung ParkOmar M Yaghi
Apr 23, 2009·Chemical Society Reviews·M D AllendorfR J T Houk
Apr 23, 2009·Chemical Society Reviews·JeongYong LeeJoseph T Hupp
Jun 9, 2011·Accounts of Chemical Research·Joseph Della RoccaWenbin Lin
Oct 8, 2011·Chemical Reviews·Jian-Rong LiHong-Cai Zhou
Dec 16, 2011·Chemical Reviews·Patricia HorcajadaChristian Serre
May 15, 2012·Dalton Transactions : an International Journal of Inorganic Chemistry·Chun-Yi SunEn-Bo Wang
Oct 23, 2015·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Bo LiuWei-Jia Kong
Apr 14, 2016·International Journal of Clinical Pharmacy·Gerben SamMatthijs Becker
Jul 11, 2016·Colloids and Surfaces. B, Biointerfaces·Zuhong HeRenjie Chai
Aug 2, 2016·Journal of the American Chemical Society·Nan DingBo Wang
Aug 4, 2016·Journal of the American Chemical Society·Dana J LevineJeffrey R Long
Aug 17, 2016·Frontiers of Medicine·Muhammad WaqasRenjie Chai
Jan 12, 2017·Journal of the American Chemical Society·Ruth RöderUlrich Lächelt
Apr 4, 2017·Advanced Materials·Ming-Xue Wu, Ying-Wei Yang
Apr 8, 2017·Journal of the American Chemical Society·Jingjing DengLanqun Mao
Aug 5, 2017·Journal of the American Chemical Society·Hasmukh A PatelJ Fraser Stoddart

❮ Previous
Next ❯

Citations

Nov 30, 2019·Frontiers in Cellular Neuroscience·Christopher RathnamKelvin Kwan
Dec 19, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Juliana C QuartermanAliasger K Salem

❮ Previous
Next ❯

Methods Mentioned

BETA
scanning electron microscopy
X-ray
infrared spectroscopy
dynamic light scattering
confocal microcopy

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.